Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
Luca Stingeni,1 Giovanna Malara,2,3 Andrea Conti,4 Luisa Di Costanzo,5 Carlo Giovanni Carrera,6 Martina Burlando,7 Piergiorgio Malagoli,8 Maria Letizia Musumeci,9 Federico Bardazzi,10 Valeria Brazzelli,11 Paolo Amerio,12 Clara De Simone,13,14 Sara Trevisini,15 Anna Balato,16 Matteo Megna,17 Francesc...
Saved in:
Main Authors: | Stingeni L (Author), Malara G (Author), Conti A (Author), Di Costanzo L (Author), Carrera CG (Author), Burlando M (Author), Malagoli P (Author), Musumeci ML (Author), Bardazzi F (Author), Brazzelli V (Author), Amerio P (Author), De Simone C (Author), Trevisini S (Author), Balato A (Author), Megna M (Author), Loconsole F (Author), De Felice C (Author), Bartezaghi M (Author), Rausa A (Author), Aloisi E (Author), Orsenigo R (Author), Costanzo A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
by: Marina Talamonti, et al.
Published: (2021) -
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
by: Talamonti M, et al.
Published: (2023) -
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
by: Antonio Costanzo, et al.
Published: (2021) -
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
by: Russo F, et al.
Published: (2023) -
Vitality Supreme
by: Macfadden, Bernarr, 1868-1955